Europe Blood Plasma Derivatives Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)

No. of Pages: 158    |    Report Code: BMIRE00028468    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Blood Plasma Derivatives Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Blood Plasma Derivatives Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Blood Plasma Derivatives Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising Demand for Blood Plasma-Based Therapies
  • 5.1.3 Increasing Geriatric Population
  • 5.1.4 Growing Prevalence of Chronic Diseases
  • 5.1.5 Technological Advancements in Plasma Fractionation
  • 5.1.6 Favorable Regulatory Environment
  • 5.1.7 Emerging Markets and Rising Healthcare Expenditure
  • 5.1.8 Strategic Partnerships and Collaborations
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Development of Novel Plasma-Derived Therapies
  • 5.2.3 Expansion into Emerging Markets
  • 5.2.4 Increased Focus on Value-Added Products
  • 5.2.5 Partnerships and Collaborations to Drive Innovation
  • 5.2.6 Advancements in Plasma Collection Technologies
  • 5.2.7 Personalized Medicine and Targeted Therapies
  • 5.2.8 Digital Health and Data Analytics
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Increased Adoption of Plasma-Based Therapies
  • 5.3.3 Advancements in Plasma Fractionation Technologies
  • 5.3.4 Personalized Medicine and Targeted Therapies
  • 5.3.5 Digital Health and Data Analytics
  • 5.3.6 Focus on Sustainability and Environmental Impact
  • 5.3.7 Emerging Markets and Rising Healthcare Expenditure
  • 5.3.8 Global Collaborations and Partnerships
5.4 Impact of Drivers and Restraints

6. Europe Blood Plasma Derivatives Market Regional Analysis

6.1 Europe Blood Plasma Derivatives Market Overview
6.2 Europe Blood Plasma Derivatives Market Revenue 2020-2028 (US$ Million)
6.3 Europe Blood Plasma Derivatives Market Forecast Analysis

7. Europe Blood Plasma Derivatives Market Analysis – by Type

7.1 Albumin
  • 7.1.1 Overview
  • 7.1.2 Albumin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Factor VIII
  • 7.2.1 Overview
  • 7.2.2 Factor VIII: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Factor IX
  • 7.3.1 Overview
  • 7.3.2 Factor IX: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Immunoglobulin
  • 7.4.1 Overview
  • 7.4.2 Immunoglobulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Hyperimmune Globulin
  • 7.5.1 Overview
  • 7.5.2 Hyperimmune Globulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Blood Plasma Derivatives Market Analysis – by Application

8.1 Hemophilia
  • 8.1.1 Overview
  • 8.1.2 Hemophilia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Hypogammaglobulinemia
  • 8.2.1 Overview
  • 8.2.2 Hypogammaglobulinemia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Immunodeficiency Diseases
  • 8.3.1 Overview
  • 8.3.2 Immunodeficiency Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 von Willebrand's Diseases
  • 8.4.1 Overview
  • 8.4.2 von Willebrand's Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Blood Plasma Derivatives Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 von Willebrand's Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 von Willebrand's Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Blood Plasma Derivatives Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Blood Plasma Derivatives Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Europe Blood Plasma Derivatives Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.1.2 UK: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Blood Plasma Derivatives Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.2.2 Germany: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Blood Plasma Derivatives Market Breakdown, by End User
  • 10.1.1.3 France: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.3.2 France: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Blood Plasma Derivatives Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.4.2 Russia: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Blood Plasma Derivatives Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.5.2 Italy: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Blood Plasma Derivatives Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Blood Plasma Derivatives Market Breakdown, by Type
    • 10.1.1.6.2 Rest of Europe: Europe Blood Plasma Derivatives Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Blood Plasma Derivatives Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Blood Plasma Derivatives Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Grifols SA
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 SK Plasma Co Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Octapharma AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Monobind Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Intas Pharmaceuticals Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 CSL Behring LLC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 LFB SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Kedrion SpA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Fusion Health Care Pvt Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Grifols SA
  2. SK Plasma Co Ltd
  3. Octapharma AG
  4. Monobind Inc.
  5. Intas Pharmaceuticals Ltd
  6. Takeda Pharmaceutical Co Ltd
  7. CSL Behring LLC
  8. LFB SA
  9. Kedrion SpA
  10. Fusion Health Care Pvt Ltd
europe-blood-plasma-derivatives-market